Skip to main content
Multiple Sclerosis Discovery Forum
Inspiring Connections
Utility Navigation
Feedback
Newsletter
RSS
Twitter
User Top Menu
Welcome, guest
Log In
Join
Why Join?
Search form
Search
About Us
Overview
Who We Are
Contact
Fan Mail
How to Cite
News & Future Directions
New Findings
News Briefs
Podcasts
News Synthesis
Essays & Opinions
Blogs
Papers
Editors' Picks
Classic Papers
Archive
Forums
Discussions
Webinars
Professional Resources
Meetings & Events
Past Meetings
Funding Opportunities
Jobs
Member Directory
Bulletin Board
Useful Links
Research Resources
Data Visualizations
Clinical Trials - Public Availability of Results
World Map
MS trials baseline
NMO History
NMO Galaxy
Map of MS Prevalence
Progressive MS Authors Galaxy
Word Cloud
MSLine
Ongoing Clinical Trials in MS
MRI-Related Clinical Trials
RRMS and CIS
Immunopathogenesis of MS
The MS Galaxy
ARR in Placebo Groups
Symptoms Prevalence
Scientific Literature TreeMap
Clinical Trials in MS
Drug-Development Pipeline
Tissue Repositories
MSGene
Animal Models
Clinical Trials
Click Here to Support MSDF
You are here
Home
Most Viewed Papers
Phase III study with teriflunomide versus placebo in patients with first clinical symptom of multiple sclerosis (TOPIC)
New Drugs Online report for idebenone
Clinically feasible MTR is sensitive to cortical demyelination in MS.
Enhancement of axonal potassium conductance reduces nerve hyperexcitability in an in vitro model of oxaliplatin-induced acute neuropathy.
Neuroprotection with glatiramer acetate: evidence from the PreCISe trial.
Dietary Fatty Acids Directly Impact Central Nervous System Autoimmunity via the Small Intestine.
Chronic cladribine administration increases amyloid Beta Peptide generation and plaque burden in mice.
Targeting ASIC1 in primary progressive multiple sclerosis: evidence of neuroprotection with amiloride.
Multiple Sclerosis and Pregnancy: Current Considerations.
Changes of serum sICAM-1 and MMP-9 induced by rIFNbeta-1b treatment in relapsing-remitting MS.
The interaction of Q analogs, particularly hydroxydecyl benzoquinone (idebenone), with the respiratory complexes of heart mitochondria.
Glatiramer acetate exposure in pregnancy: preliminary safety and birth outcomes.
Interferon-beta in pediatric multiple sclerosis patients: safety in short-term prescription.
Rituximab product approval information - Licensing action
Development of interferon beta-neutralising antibodies in multiple sclerosis-a systematic review and meta-analysis.
Meningeal inflammation plays a role in the pathology of primary progressive multiple sclerosis.
Santhera and NIH collaborate to evaluate Catena® in primary progressive multiple sclerosis
Effect of Glatiramer Acetate on Peripheral Blood Brain-Derived Neurotrophic Factor and Phosphorylated TrkB Levels in Relapsing-Remitting Multiple Sclerosis.
Serum from interferon-β-1b-treated patients with early multiple sclerosis stabilizes the blood-brain barrier in vitro.
Integrated genomic and prospective clinical studies show the importance of modular pleiotropy for disease susceptibility, diagnosis and treatment.
Magnetic resonance imaging pattern in natalizumab-associated progressive multifocal leukoencephalopathy.
Use of amiloride and multiple sclerosis: registry-based cohort studies.
Zebrafish myelination: a transparent model for remyelination?
Thrombotic microangiopathy associated with use of interferon-beta.
Minocycline added to subcutaneous interferon β-1a in multiple sclerosis: randomized RECYCLINE study.
Pages
« first
‹ previous
…
64
65
66
67
68
69
70
71
72
…
next ›
last »